Kinshasa Medical Oxford Research Unit (KIMORU) Report issue

Academic/Hospital Phase 3
Founded: Kingasani Congo (2009)

Organization Overview

First Clinical Trial
2020
NCT04251351
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kinshasa Medical Oxford Research Unit

Active Ingredients

Drugs in Phase 3 Trials (1)

acetaminophen (tylenol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 3)

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1